Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Beijing, Changsha, Hangzhou, Shanghai
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00 - Phase 1Not yet taking people in ChinaA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Beijing, Tianjin
- Age
- 18 years and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00 - Phase 1Not yet taking people in ChinaA Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Where
- Shanghai
- Age
- 18 years and over
- People
- 340 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213791 · EU 2025-521887-37-00 - No phaseTaking peopleRemimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy
- Where
- Nanjing
- Age
- 65 years to 100 years
- People
- 170
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07351474 - Phase 1Not yet taking people in ChinaSND002 Cell Injection in Participants With Advanced Malignant Solid Tumors
- Where
- Guiyang, Hangzhou
- Age
- 18 years to 80 years
- People
- 78
- Run by
- Guizhou Sinorda Pharmaceutical Co., Ltd.
See details and how to joinNCT07903857 - No phaseNot yet taking people in ChinaMulti-center Prospective Validation of Real-Time AI-EGGIM System
- Where
- Binzhou, Jinan, Qingdao
- People
- 540
- Run by
- Qilu Hospital of Shandong University
See details and how to joinNCT07915843 - Phase 2Taking peopleA Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
- Where
- Beijing, Changchun, Changzhi, Chengdu, Fuzhou, Hangzhou, Kunming, Qingdao, Shanghai, Shijiazhuang
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07069712 · EU 2024-516909-23-00 - No phaseTaking peopleTEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial)
- Where
- Dongying, Qingdao, Rizhao, Weifang, Weihai, Yantai
- Age
- 18 years to 80 years
- People
- 300
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT07714980 - Phase 2Not yet taking people in ChinaD2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy for Gastric Cancer
- Where
- Nanjing
- Age
- 18 years to 75 years
- People
- 32
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07912606 - Phase 2Not yet taking people in ChinaNeoadjuvant SHR-A1811 ± Adebrelimab in GC/GEJ
- Where
- Shanghai
- Age
- 18 years and over
- People
- 62
- Run by
- Fudan University
See details and how to joinNCT07912957 - Phase 2Taking peopleQL1706 Plus Celecoxib in Advanced Esophageal Squamous Cell Carcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 35
- Run by
- Peking University Cancer Hospital & Institute
See details and how to joinNCT07049185 - Phase 3Taking peopleA Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 438
- Run by
- Biokin (Shanghai) Biopharmaceutical Co., Ltd.
See details and how to joinNCT07518147 - No phaseTaking peopleTEAS for Gastrectomy Recovery
- Where
- Qingdao, Rizhao, Weifang, Yantai
- Age
- 18 years to 80 years
- People
- 104
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT07898293 - Phase 1Taking peopleA Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors
- Where
- Shanghai
- Age
- 18 years and over
- People
- 128
- Run by
- TJ Biopharma Co., Ltd.
See details and how to joinNCT07715747 - Phase 2Taking peopleAdebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
- Where
- Fuzhou
- Age
- 18 years to 70 years
- People
- 48
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT06510660 - Phase 2Taking peopleBiomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
- Where
- Fuzhou
- Age
- 18 years to 75 years
- People
- 90
- Run by
- Fujian Medical University Union Hospital
See details and how to joinNCT06601309 - Phase 3Taking peopleA Study of ATG-022 Compared With Investigator's Choice of Treatment in Claudin 18.2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Anyang, Baoding, Beijing, Bengbu, Binzhou, Cangzhou, Changchun, Changsha, Changzhi, Changzhou, Chaoyang, Chengdu, Chongqi, Dalian, Fuyang, Fuzhou, Ganzhou, Guangzhou, Haikou, Handan, Hangzhou, Harbin, Hefei, Hohhot, Huai'an, Huzhou, Jiangyin, Jiaxing, Jinan, Jinhua, Kunming, Lanzhou, Liaocheng, Linhai, Lishui, Luoyang, Nanchang, Nanjing, Nantong, Nanyang, Neijiang, Pingxiang, Qingdao, Sanmenxia, Shanghai, Shantou, Shenyang, Shenzhen, Shijiazhuang, Suining, Suzhou, Taiyuan, Taizhou, Tengzhou, Tianjin, Ürümqi, Weifang, Weihai, Wenzhou, Wuhan, Wuwei, Xiamen, Xi’an, Xiangyang, Xinxiang, Xuzhou, Yangzhou, Yantai, Yibin, Yinchuan, Zhengzhou, Zhumadian, Zibo
- Age
- 18 years and over
- People
- 380
- Run by
- Antengene Biologics Limited
See details and how to joinNCT07795346 - No phaseNot yet taking people in ChinaLymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma
- Where
- Lianyungang, Nanjing, Qingdao, Shanghai, Shijiazhuang, Suzhou
- Age
- 18 years and over
- People
- 2,000
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07902596 - No phaseNot yet taking people in ChinaEffect of High-flow Nasal Cannula Oxygenation on the Incidence of Hypoxemia During Painless Gastrointestinal Endoscopy in Patients at High Risk for Obstructive Sleep Apnea Syndrome in High-altitude Regions
- Where
- Hangzhou, Sanjiaocheng, Xining
- Age
- 18 years and over
- People
- 430
- Run by
- Diansan Su
See details and how to joinNCT07904260 - No phaseTaking peopleOral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer
- Where
- Baotou, Beijing, Chengdu, Dalian, Fuzhou, Hangzhou, Harbin, Hohhot, Nanning, Qiqihar, Shanghai, Shijiazhuang, Suzhou, Wuhan, Yinchuan
- Age
- 18 years to 75 years
- People
- 150
- Run by
- Harbin Medical University
See details and how to joinNCT07552402 - Phase 3Taking peopleA Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
- Where
- Anyang, Beijing, Changchun, Changzhou, Chengdu, Fuzhou, Hangzhou, Harbin, Hefei, Jieyang, Jinan, Jining, Linyi, Luoyang, Nanning, Shantou, Shenyang, Tianjin, Weihui, Wuhan, Xiamen, Yangzhou, Zhengzhou
- Age
- 18 years and over
- People
- 510 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06644781 · EU 2023-509630-19-00 - Phase 3Taking peopleStratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study
- Where
- Tianjin
- Age
- 18 years to 75 years
- People
- 340
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07246330 - Phase 2Taking peopleHIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 48
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT07621484 - Phase 3Taking peopleModular Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Esophageal Cancer
- Where
- Shanghai
- Age
- 18 years and over
- People
- 160
- Run by
- Ruijin Hospital
See details and how to joinNCT07888140 - Phase 1/2Taking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Baoding, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Linyi, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taizhou, Tianjin, Wuhan, Xi’an, Xinxiang, Zhengzhou
- Age
- 18 years and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116